CD86 and adenoma: Multivariate regression further confirmed this relationship: CD163+ TAMs (β = 7545.441, 95% CI: 5575.552 ~ 9515.329) and CD86+ TAMs (β = 4488.870, 95% CI: 3477.967 ~ 5499.773) were significantly increased in patients with larger adenomas.